Patient Guide: Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06435273
Status: ACTIVE_NOT_RECRUITING
Condition: Asthma
Phase: PHASE2

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Calgary, Alberta
  • • Vancouver, British Columbia
  • • Montréal, Quebec
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma - Join Clinical Trial NCTNCT06435273

How to Join This Clinical Trial - NCTNCT06435273

Learn how to participate in this PHASE2 trial studying an investigational therapy for Asthma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Asthma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Asthma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06435273 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Calgary, Alberta T2N 4Z6 - Canada

Status: Contact for availability

Clinical Research Site

Vancouver, British Columbia V5Z 1M9 - Canada

Status: Contact for availability

Clinical Research Site

Montréal, Quebec H4A 3J1 - Canada

Status: Contact for availability

Clinical Research Site

Quebec, G1V 4G5 - Canada

Status: Contact for availability

Clinical Research Site

Aalborg, 9100 - Denmark

Status: Contact for availability

Clinical Research Site

Hvidovre, 2650 - Denmark

Status: Contact for availability

Clinical Research Site

København NV, 2400 - Denmark

Status: Contact for availability

Clinical Research Site

Vejle, 7100 - Denmark

Status: Contact for availability

Clinical Research Site

Frankfurt, 60596 - Germany

Status: Contact for availability

Clinical Research Site

Grosshansdorf, 22927 - Germany

Status: Contact for availability

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Asthma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships